4/A: CME Group Executive Updates Beneficial Ownership After Performance Share Award and Trust Transfer
SEC Filing
Derek Sammann, Senior Managing Director at CME Group, amends his Form 4 to reflect changes in beneficial ownership following a performance share award and a transfer of stock to a revocable living trust.
Summary
- Derek Sammann, a Senior Managing Director at CME Group, filed an amended Form 4 with the SEC.
- The amendment updates his beneficial ownership of CME Group Class A common stock.
- The changes are due to shares earned from a 2021 performance share award and a transfer of stock to his revocable living trust on October 31, 2024.
- On March 15, 2025, Mr. Sammann acquired 3,883 shares at $258.68 related to the performance share award.
- He also surrendered 1,708 shares on March 15, 2025, at $258.68 to cover tax withholding obligations.
- After these transactions, Mr. Sammann directly owns 11,592 shares.
- He also indirectly owns 10,811 shares through his spouse and 14,614 shares through a trust.
Sentiment
Score: 6
Explanation: The document is neutral in sentiment as it primarily reports transactions related to executive compensation and estate planning. The vesting of performance shares is a positive signal, but the overall impact is limited.
Positives
- The performance share award indicates that the company met its total shareholder return targets relative to the S&P 500 over the period 2022-2024.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing reflects standard compensation practices and estate planning activities.
Comparison to Industry Standards
- Performance share awards are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.
- The vesting of performance share awards based on total shareholder return relative to the S&P 500 is a typical metric used to incentivize long-term value creation.
- Transferring assets to a revocable living trust is a standard estate planning strategy employed by many individuals, including corporate executives.
Stakeholder Impact
- The vesting of performance shares could be viewed positively by shareholders as it indicates the company met its performance targets.
Key Dates
| Date | Description |
|---|---|
| 2021 | Grant date of the performance share award. |
| 2022-2024 | Measurement period for the performance share award based on total shareholder return relative to the S&P 500. |
| 2024-10-31 | Date of transfer of CME Group Class A common stock to reporting person's revocable living trust. |
| 2025-03-15 | Date of transaction for acquisition and disposal of shares related to the performance share award. |
| 2025-03-18 | Date of original Form 4 filing. |
| 2025-05-05 | Date of amended Form 4/A filing. |
Keywords
Form 4, Beneficial Ownership, CME Group, Sammann, Performance Share Award, Revocable Living Trust, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.